[1]高慧.中西医结合对慢性乙型病毒性肝炎高胆红素血症患者肝功能及免疫功能的影响[J].西部中医药,2020,33(02):99-103.[doi:10.12174/j.issn.1004-6852.2020.02.28]
　GAO Hui.Influence of Integrative Medicine on Liver Function and Immunologic Function in Chronic Viral Hepatitis B Patients with Hyperbilirubinemia[J].Western Journal of Traditional Chinese Medicine,2020,33(02):99-103.[doi:10.12174/j.issn.1004-6852.2020.02.28]
点击复制

中西医结合对慢性乙型病毒性肝炎高胆红素血症患者肝功能及免疫功能的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年02期
页码:
99-103
栏目:
出版日期:
2020-02-15

文章信息/Info

Title:
Influence of Integrative Medicine on Liver Function and Immunologic Function in Chronic Viral Hepatitis B Patients with Hyperbilirubinemia
文章编号:
1004-6852(2020)02-0099-05
作者:
高慧
榆林市中医医院肝胆科，陕西 榆林 719000
Author(s):
GAO Hui
Department of Hepatology, Yulin City TCM Hospital, Yulin 719000, China
关键词:
肝炎; 乙型; 高胆红素血症; 中西医结合; 退黄合剂; 直肠滴入; 肝功能; 免疫功能
Keywords:
hepatitis;  B;  hyperbilirubinemia;  integrative medicine;  Tuihuang mixture;  rectum dripping; liver function;  immunologic function
分类号:
R512.6+2
DOI:
10.12174/j.issn.1004-6852.2020.02.28
摘要:
目的：探讨中药退黄合剂直肠滴入与内科综合疗法联合应用对慢性乙型病毒性肝炎(chronicviral hepatitis B)高胆红素血症患者肝功能及免疫功能的影响。方法：用随机抽签法将96例CHB高胆红素血症患者分为两组，每组48例，对照组仅接受内科综合治疗，观察组在实施内科综合治疗基础上，给予退黄合剂直肠滴入治疗。观察两组治疗前后免疫功能(CD4+、CD8+、CD3+、补体C3、免疫球蛋白G(immunoglobulin G，IgG)、免疫球蛋白M(immunoglobulin M，IgM)、免疫球蛋白A(immunoglobulin A，IgA)、肝功能谷丙转氨酶(glutamic-pyruvic transaminase，ALT)、谷草转氨酶(glutamic-oxalacetic transaminase，AST)、透明质酸(hyaluronic acid，HA)、Ⅳ型胶原(type Iv collagen，IV-C)、血清血红素(TBI、DBL)含量及PTa变化情况；对比2组治疗后临床效果。结果：治疗后，两组患者血清中T淋巴细胞亚群CD4+、CD3+、IgG及IgM含量明显升高(P＜0.05)，CD8+含量及补体C3表达水平降低(P＜0.05)，CD4+/CD8+值增大(P＜0.05)，且观察组CD4+、CD3+、IgG及IgM含量及CD4+/CD8+值均高于对照组(P＜0.05)，CD8+含量及补体C3表达水平低于对照组(P＜0.05)；两组患者肝功能指标ALT、AST、HA、IV-C及血清总胆红素(total bilirubin，TBIL)、直接胆红素(direct bilirubin，DBL)含量下降(P＜0.05)，且PTa明显增大(P＜0.05)，观察组各指标水平明显优于对照组(P＜0.05)。观察组临床总有效率91.67%（43/48），对照组70.83%（34/48），两组比较差异有统计学意义(P＜0.05)。结论：退黄合剂直肠滴入法联合内科综合疗法，可显著提高CHB高胆红素血症患者免疫功能，抑制肝脏组织纤维化，改善肝脏功能，降低胆红素含量，提高临床治疗效果。
Abstract:
Objective: To discuss the effects of rectum dripping of Tuihuang mixture joined with comprehensive therapy of internal medicine on liver function and immunologic function of chronic viral hepatitis B (CHB) patients with hyperbilirubinemia. Methods: All 96 patients were randomized into two groups using random sampling method, 48 cases each group, the control group accepted comprehensive therapy of internal medicine, and the observation group rectum dripping of Tuihuang mixture based on comprehensive therapy of internal medicine. To observethe changes of PTa, the contents of serum heme (TBI and DBL), liver function (ALT, AST, HA and Ⅳ-C) and immunologic function (CD4+, CD8+, CD3+, complements C3, IgG, IgM and IgA) before and after treating in both groups; to compare clinical effects after treating between both groups. Results: After treating, the contents of T lymphocyte subsets CD4+, CD3+, IgG and IgM in both groups rose notably (P＜0.05), the contents of CD8+ and the expressions of complement C3 reduced (P＜0.05), CD4+/CD8+ increased (P＜0.05), and the observation group was higher than the control group in the contents of CD4+, CD3+, IgG and IgM, CD4+/CD8+(P＜0.05), lower than the control group in the contents of CD8+ and the expressions of complement C3(P＜0.05); liver function indexes ALT, AST, HA and IV-C and the contents of TBIL and DBL in both groups lowered (P＜0.05), and PTa rose notably (P＜0.05), the observation group was superior to the control group in the levels of all the indexes apparently (P＜0.05). Clinical total effective rate of the observation group was 91.67% (43/48), higher than 70.83% (34/48) of the control group, and the difference had statistical meaning (P＜0.05). Conclusion: The combination of rectum dripping of Tuihuang mixture and comprehensive therapy of internal medicine could notably lift immunologic function of CHB patients, inhibit hepatic fibrosis, improve liver function, reduce the contents of bilirubin and raise clinical therapeutic effects.

相似文献/References:

[1]陈芳玉,张杰,毛莲香,等.疏肝健脾化痰汤治疗非酒精性脂肪性肝炎50例[J].西部中医药,2015,28(06):94.[doi:2015/6/16 0:00:00]
[2]叶佩燕,苗慧,杨宗国,等.解毒逐瘀方保留灌肠治疗早中期慢性重型肝炎患者的临床观察[J].西部中医药,2012,25(07):1.
　YE Pei-yan,MIAO Hui,YANG Zong-guo,et al.Clinical Observation on Chronic Severe Hepatitis at Early-Middle Stage Treated with Retention Enema of JieDu ZhuYuFang[J].Western Journal of Traditional Chinese Medicine,2012,25(02):1.
[3]李明淑,陶桂云,秦建梅,等.白银地区丙型肝炎病毒感染的基因型特征研究[J].西部中医药,2014,27(04):63.
　LI Mingshu,TAO Guiyun,QIN Jianmei,et al.Investigation on Genetic Features of Hepatitis C Virus Infection in Baiyin District[J].Western Journal of Traditional Chinese Medicine,2014,27(02):63.
[4]于晨媛.茵陈蒿汤加味联合西药治疗慢性丙型肝炎65例[J].西部中医药,2013,26(09):82.
　YU Chenyuan.Modified YinChenHao Tang Combined with Western Medicine for 65 Cases of Chronic Hepatitis C[J].Western Journal of Traditional Chinese Medicine,2013,26(02):82.
[5]李象霖,魏世芳,张月萍,等.中西医结合治疗非嗜肝病毒所致急性黄疸型肝炎临床观察[J].西部中医药,2014,27(05):102.
　LI Xianglin,WEI Shifang,ZHANG Yueping,et al.Curative Observation on Treating Nonhepadnaciridae-induced Acute Icteric Hepatitis by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(02):102.
[6]曼琼,吴晶,牛晨霞,等.护肝颗粒治疗各型肝炎76例[J].西部中医药,2016,29(05):74.
　MAN Qiong,WU Jing,NIU Chenxia,et al.Liver-protection Granules in Treating 76 Cases of Various Types of Hepatitis[J].Western Journal of Traditional Chinese Medicine,2016,29(02):74.
[7]邓恺伦.疏肝降脂汤治疗肝郁脾虚型非酒精性脂肪肝44例[J].西部中医药,2020,33(04):96.[doi:10.12174/j.issn.1004-6852.2020.04.29]
　DENG Kailun.Liver-soothing Lipid-lowering Decoction in Treating 44 Cases of Nonalcoholic Steatohepatitis of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2020,33(02):96.[doi:10.12174/j.issn.1004-6852.2020.04.29]
[8]许海燕,彭修娟,王珊,等.基于网络药理学的龙胆抗炎镇痛及治疗肝炎的作用机制研究[J].西部中医药,2020,33(08):54.[doi:10.12174/j.issn.1004-6852.2020.08.15]
　XU Haiyan,PENG Xiujuan,WANG Shan,et al.The Study on the Mechanism of Longdan Fighting Against Inflammation and Easing Pain and Treating Hepatitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2020,33(02):54.[doi:10.12174/j.issn.1004-6852.2020.08.15]
[9]延保国.还原型谷胱甘肽联合苦黄注射液治疗慢性乙型肝炎40例疗效观察[J].西部中医药,2012,25(09):68.
　YAN Bao-guo.Curative Observation on Reduced Glutathione for Injection and KuHuang Injection in Treating 40 Cases of Chronic Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2012,25(02):68.
[10]何晶,袁征,陆原,等.基于数据挖掘探讨周珉教授治疗慢性乙型肝炎的用药规律及经验[J].西部中医药,2021,34(06):81.[doi:10.12174/j.issn.2096-9600.2021.06.19]
　HE Jing,YUAN Zheng,LU Yuan,et al.Professor Zhou Min′s Medication Rules and Experience of Treating Chronic Hepatitis B Based on Data Mining[J].Western Journal of Traditional Chinese Medicine,2021,34(02):81.[doi:10.12174/j.issn.2096-9600.2021.06.19]
[11]陈泽山,朱文琳,陈柏尧,等.从湿热中阻论治慢性乙型肝炎研究进展[J].西部中医药,2023,36(02):133.[doi:10.12174/j.issn.2096-9600.2023.02.31]
　CHEN Zeshan,ZHU Wenlin,CHEN Baiyao,et al.Research Progress of Treatment of Chronic Hepatitis B from Damp-heat Obstructing the Middle Energizer[J].Western Journal of Traditional Chinese Medicine,2023,36(02):133.[doi:10.12174/j.issn.2096-9600.2023.02.31]
[12]蒙荫杰,邱华,黄鹏,等.白花香莲解毒颗粒治疗HBeAg阳性慢性乙型肝炎的临床疗效及对血浆外泌体miR-122表达的影响[J].西部中医药,2023,36(06):110.[doi:10.12174/j.issn.2096-9600.2023.06.26]
　MENG Yinjie,QIU Hua,HUANG Peng,et al.Clinical Effects of Baihua Xianglian Detoxification Granules in the Treatment of Positive HBeAg Chronic Hepatitis B and Its Influence on Plasma Exosomal miR-122 Expressions[J].Western Journal of Traditional Chinese Medicine,2023,36(02):110.[doi:10.12174/j.issn.2096-9600.2023.06.26]
[13]李彦波,吕文良,强睿,等.吕文良教授“火候”学理论治疗慢性乙型病毒性肝炎[J].西部中医药,2024,37(04):42.[doi:10.12174/j.issn.2096-9600.2024.04.09]
　LI Yanbo,LYU Wenliang,QIANG Rui,et al.Professor Lyu Wenliang′s "Fire" Theory in the Treatment of Chronic Viral Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2024,37(02):42.[doi:10.12174/j.issn.2096-9600.2024.04.09]

备注/Memo

备注/Memo:
收稿日期：2019-05-30作者简介：高慧(1980—)，女，主治医师。研究方向：肝胆脾胃相关疾病的诊治。
更新日期/Last Update: 2020-02-15